Pioglitazone use and bladder cancer risk: a population-based cohort study.

Pioglitazone use and bladder cancer risk: a population-based cohort study.

Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L. Pioglitazone use and bladder cancer risk: a population-based cohort study. BMJ. 2016 Mar 30;352:i1541.

View All Publications